Humana sues Biden admin over Medicare Advantage audit rule

HumanasuedthefederalgovernmentFridayoverarulethatclawsbackoverpaymentsfromitandotherMedicareAdvantag 3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport




leisure time

author：explore    Page View：279
Alexis Borisy
Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

advertisement

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In
Previous article： Covid hospitalizations on the rise, Humana says
Next article： Dobbs anniversary: the lost opportunity of abortion as health care